Recent Advances in the Development of Vaccines for Diabetes, Hypertension, and Atherosclerosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Advances in the Development of Vaccines for Diabetes, Hypertension, and Atherosclerosis
Authors
Keywords
-
Journal
Journal of Diabetes Research
Volume 2018, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2018-09-25
DOI
10.1155/2018/1638462
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders
- (2018) Claudia Floriana Suciu et al. AUTOIMMUNITY REVIEWS
- The therapeutic potential of CETP inhibitors: a patent review
- (2018) Xinran Wang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Therapeutic vaccine against IL-1β improved glucose control in a mouse model of type 2 diabetes
- (2018) Yue Zhang et al. LIFE SCIENCES
- The link between depression and atherosclerosis through the pathways of inflammation and endothelium dysfunction
- (2018) Christina Chrysohoou et al. MATURITAS
- Coronary Artery Disease
- (2018) Stephen D. Cagle et al. PRIMARY CARE
- Prevention of Cardiovascular Disease
- (2018) Brian V. Reamy et al. PRIMARY CARE
- Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
- (2018) Irene Maeve Rea et al. Frontiers in Immunology
- Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations
- (2018) Willem M. Kühtreiber et al. npj Vaccines
- The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
- (2017) Christine Landlinger et al. EUROPEAN HEART JOURNAL
- β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome
- (2017) Marisa Benagiano et al. JOURNAL OF IMMUNOLOGY
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- (2017) A. Michael Lincoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Construction of a novel vaccine by conjugating a B-cell epitope of DPP4 to peptide IA2(5)-P2-1 to significantly control type 1 diabetes in NOD mice
- (2017) Ya Li et al. VACCINE
- A Therapeutic Peptide Vaccine Against PCSK9
- (2017) Yajie Pan et al. Scientific Reports
- Inflammation in atherosclerosis
- (2016) Soraya Taleb Archives of Cardiovascular Diseases
- Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study
- (2016) Nobuaki Suzuki et al. CANCER SCIENCE
- Global Disparities of Hypertension Prevalence and ControlClinical Perspective
- (2016) Katherine T. Mills et al. CIRCULATION
- Vaccine strategies for lowering LDL by immunization against proprotein convertase subtilisin/kexin type 9
- (2016) Bryce Chackerian et al. CURRENT OPINION IN LIPIDOLOGY
- GAD vaccine reduces insulin loss in recently diagnosed type 1 diabetes: findings from a Bayesian meta-analysis
- (2016) Craig A. Beam et al. DIABETOLOGIA
- Environmental risk factors for type 1 diabetes
- (2016) Marian Rewers et al. LANCET
- Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
- (2016) Claudia Cavelti-Weder et al. MOLECULAR THERAPY
- Interleukin-1β-Targeted Vaccine Improves Glucose Control and β-Cell Function in a Diabetic KK-Ay Mouse Model
- (2016) Jun Zha et al. PLoS One
- Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches
- (2016) Chary López-Pedrera et al. RHEUMATOLOGY
- Reality of a Vaccine in the Prevention and Treatment of Atherosclerosis
- (2015) Victor García-González et al. ARCHIVES OF MEDICAL RESEARCH
- Vaccination to modulate atherosclerosis
- (2015) Takayuki Kimura et al. AUTOIMMUNITY
- Heat Shock Proteins: Mediators of Atherosclerotic Development
- (2015) Justin Deniset et al. CURRENT DRUG TARGETS
- About the gut microbiome as a pharmacological target in atherosclerosis
- (2015) Julia J. Witjes et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Long-Term Reduction of High Blood Pressure by Angiotensin II DNA Vaccine in Spontaneously Hypertensive RatsNovelty and Significance
- (2015) Hiroshi Koriyama et al. HYPERTENSION
- Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy
- (2015) Dan Ding et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- A cholesterol-lowering VLP vaccine that targets PCSK9
- (2015) Erin Crossey et al. VACCINE
- Phase II trial of combination therapy of gemcitabine plus anti-angiogenic vaccination of elpamotide in patients with advanced or recurrent biliary tract cancer
- (2014) Masato Matsuyama et al. INVESTIGATIONAL NEW DRUGS
- Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system
- (2014) Diego Moricoli et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
- (2014) Dirk J. Blom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic vaccine against DPP4 improves glucose metabolism in mice
- (2014) Zhengda Pang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global estimates of diabetes prevalence for 2013 and projections for 2035
- (2013) L. Guariguata et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries
- (2013) Clara K. Chow JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus
- (2013) Atsushi Iwabuchi et al. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice
- (2013) Futoshi Nakagami et al. PLoS One
- Therapeutic Vaccines against Human and Rat Renin in Spontaneously Hypertensive Rats
- (2013) Zhihua Qiu et al. PLoS One
- A perspective for atherosclerosis vaccination: Is there a place for plant-based vaccines?
- (2013) Jorge Alberto Salazar-González et al. VACCINE
- Obesity vaccines
- (2013) Mariana P Monteiro Human Vaccines & Immunotherapeutics
- Hypertension Vaccine may be a boon to millions in developing world
- (2013) Mohan Bairwa et al. Human Vaccines & Immunotherapeutics
- Effectiveness and Safety of a Therapeutic Vaccine Against Angiotensin II Receptor Type 1 in Hypertensive Animals
- (2012) Xiao Chen et al. HYPERTENSION
- Nasal immunization with different forms of heat shock protein-65 reduced high-cholesterol-diet-driven rabbit atherosclerosis
- (2012) Jun Long et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes
- (2012) S. Cornell JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus
- (2012) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes
- (2012) Denise L. Faustman et al. PLoS One
- Vaccination of non-obese diabetic mice with a fragment of peptide P277 attenuates insulin-dependent diabetes mellitus
- (2011) Yan-Jun Ma et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
- (2011) Diane K Wherrett et al. LANCET
- Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine
- (2010) M. Wigren et al. JOURNAL OF INTERNAL MEDICINE
- The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies
- (2010) S. Yende et al. THORAX
- Immunization against angiotensins for the treatment of hypertension
- (2009) Patrik Maurer et al. CLINICAL IMMUNOLOGY
- A vaccine for hypertension based on peptide AngI-R: A pilot study
- (2009) Fang Hong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
- (2009) Roger Yazbeck et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice
- (2008) E. J.A. van Wanrooij et al. CARDIOVASCULAR RESEARCH
- Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies
- (2008) G. N. Fredrikson et al. JOURNAL OF INTERNAL MEDICINE
- Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study
- (2008) Alain C Tissot et al. LANCET
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes
- (2008) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search